Condition
Broader IBD news covering Crohn's disease, ulcerative colitis, research, treatments, monitoring, and patient care.
Page 21 of 88 · 4183 articles
Cure8 could only read part of this source from fox2detroit.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and awareness.
Cure8 found this source from onlinelibrary.wiley.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Upadacitinib. Open the original article for the full...
If confirmed, starting effective biologic therapy at diagnosis could lower the chance of surgery and complications over several years for people with moderate-to-severe Crohn’s disease.
The release reports many active and planned clinical trials for Crohn’s disease that could lead to new treatment options in coming years. It names specific late-stage and combination studies relevant to patients with...
Reported IBD rates in Brazil increased markedly between 2012 and 2025, which could mean more people will need diagnosis, specialist care, and medications. Rising numbers also matter for public-health planning and...
This study compares first‑line vedolizumab versus TNF antagonist strategies in biologic‑naive ulcerative colitis patients over multiple years — information that could affect treatment choice and expectations about...
Finding reliable diagnostic biomarkers could help detect UC earlier and clarify immune mechanisms that drive disease; GPR97 is proposed here as such a marker and a possible immunomodulatory target, which may interest...
Spatial mapping of immune niches in refractory UC identified tissue signatures (neutrophil-rich ulcer-bed niches and TLS/plasma-cell programmes) that were associated with failure to respond to biologic drugs across adult...
This review reframes IBD as a systemic disease influenced by gut microbes, metabolism, and immune interactions — which matters because it points toward better ways to stratify patients, monitor disease, and personalize...
Dietary choices can affect disease activity, remission maintenance, nutrition status, and quality of life for people with IBD. This review summarizes current, evidence-based, phase-specific guidance that can inform care.
Based on the title and source metadata, this appears to be a clinical study related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Drug Delivery and...
This trial tests several targeted therapies (including risankizumab) alone and in combination for adults with moderate to severe Crohn's disease, aiming to measure endoscopic remission and safety. Positive findings could...
This study suggests a specific four-strain probiotic cocktail may better protect against experimental colitis than the three-strain mix, potentially via microbiota-driven increases in spermidine — a microbial metabolite...
Distinguishing colorectal cancer from IBD-related inflammatory thickening can be challenging but crucial for treatment decisions. If validated, DECT parameters could offer a noninvasive tool to improve diagnostic...
People with IBD may be interested because the review highlights a class of dietary polyphenols that could influence inflammation and immune pathways involved in Crohn’s disease and ulcerative colitis. It summarizes...
Based on the title and source metadata, this appears to be a basic science related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from Nature Genetics.
Many people with IBD want to be active but face symptom-related and psychosocial barriers; low awareness but strong interest in Adapted Physical Activity programs suggests opportunity to add structured, personalized...
People who have both IBD and type 2 diabetes are at increased cardiovascular risk; this study suggests GLP-1–based therapies may be associated with lower rates of several heart and thrombotic events in that group.
This study identifies a fibroblast-ILC3-pDC pathway that may help restrain gut inflammation and appears reduced in IBD tissue, highlighting a new non-immune cell mechanism relevant to disease biology.
The paper identifies a neutrophil-related immune pathway (KARAP → IDO1–kynurenine → AhR → IL-22) that contributes to mucosal inflammation in ulcerative colitis, suggesting a potential new target for research and drug...
Cure8 found this source from kfyrtv.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the full...
Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the full...
This label update affects people with IBD because golimumab (SIMPONI) is an approved anti‑TNF treatment for ulcerative colitis and the label includes safety changes and pediatric dosing information that could affect...
Diet and meal preparation can affect comfort and symptom management for many people with IBD. Free, curated recipe tools make it easier to find meals suited to sensitive digestive tracts without trial-and-error.
People with IBD are at higher risk for shingles largely because of immunosuppressive treatments; an effective vaccine (RZV) is recommended by major societies but is underused in some places.
Atypical presentations of Crohn's disease (abdominal wall abscess with enterocutaneous fistula) can delay diagnosis and treatment in children. Patients with communication difficulties may be at higher risk for missed or...
Based on the title and source metadata, this appears to be a video related to Crohn's disease, Inflammatory bowel disease, and Procedures and surgery. The original article is from hmpgloballearningnetwork.com.
Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Inflammation Research.
Cure8 found this source from ozarksfirst.com, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and awareness. Open the original article for the full...
Patients receiving immune checkpoint inhibitors can develop ICI‑induced colitis that resembles IBD and may not respond to steroids. This review discusses advanced biologic and targeted therapies used when steroids fail,...
Based on the title and source metadata, this appears to be a case report related to Ulcerative colitis, Inflammatory bowel disease, and Ustekinumab. The original article is from Immunological Medicine.
This review highlights a plant-derived compound, ferulic acid, that showed anti-colitis effects in experimental studies, suggesting a potential new adjunctive therapy pathway worth watching for future clinical research.
Scholarships and peer communities can ease the financial and emotional burden of living with IBD and help students find supportive networks and career inspiration. Stories like these highlight practical resources and the...
This study provides real-world evidence about using upadacitinib as a maintenance therapy in children with refractory Crohn’s disease — a group with limited treatment options.
Based on the title and source metadata, this appears to be a patient education related to Ulcerative colitis, Inflammatory bowel disease, and Procedures and surgery. The original article is from Baylor University Medical...
This study compares bloodstream infection risk across commonly used biologics for IBD, which could affect decisions about choosing or monitoring biologic therapy. It also highlights that steroid co-use may increase...
Dietary approaches that reduce gut inflammation could offer a low‑risk option to help manage symptoms and biomarkers in Crohn’s disease. This trial specifically tests a catered anti‑inflammatory diet and measures fecal...
Hospitalized patients with acute severe ulcerative colitis face high risks of colectomy and steroid-related harms. This trial tests whether an oral JAK1 inhibitor (upadacitinib) started in hospital can avoid steroids,...
This post‑marketing study will add safety and real‑world effectiveness information about Tabellvi® (adalimumab) in Chinese adults with moderate to severe Crohn's disease, which can inform patients and clinicians using or...
Real-world registries can show how a drug performs outside clinical trials and how patients feel over time; this study aimed to track symptoms for people starting mirikizumab for ulcerative colitis.
If true, prenatal and early-life exposures could influence long-term IBD risk by shaping immune development and the gut microbiome, which may help explain why some people develop IBD and others don’t.
Diet is a modifiable factor many people with IBD try to use to manage symptoms and disease; this review summarizes what is and isn’t supported by current evidence for popular diets and structured nutritional therapies.
The study suggests active smoking reduces the effectiveness of anti-TNF biologics in people with IBD, which could affect treatment response and the need to switch or escalate therapies. This supports including smoking...
Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and AI and data science. The original article is from Toxicological Research.
Based on the title and source metadata, this appears to be an opinion or commentary related to Inflammatory bowel disease and Research and clinical trials. The original article is from Expert opinion on emerging drugs.
Dose increases are common during IBD maintenance and vary a lot by drug and patient profile. Knowing which treatments and patient factors are linked to escalation can help patients and clinicians plan monitoring and...
High first-use usability suggests MyTARGET could be acceptable to many adults with IBD and that targeted refinements (error handling, demonstrating time savings) might improve uptake and recommendation.
Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from The Turkish journal of...
